Canada as a World Leading Destination for Clinical Trials
Idiosyncrasies in our business landscape, once viewed as innocuous inconveniences, are now costing Canada substantially in lost opportunity. When a company interested in conducting clinical trials comes to Canada, it faces multiple challenges which can result in costs and delays, and ultimately discourage Clinical Trial investment in Canada.
HealthCareCAN‘s aim is to help clinical trial companies succeed and stay in Canada. Our goals are to: (1) halt and reverse the downward trend in clinical trial investments; (2) improve business practices as they pertain to clinical trial operations; and (3) create a stable, forward looking opportunity for clinical trials into the future.
They bring safe, innovative, & effective drugs to market
Their million-dollar contracts create jobs for Canadians
They can result in cost savings to our health system
They can improve quality of life for millions of Canadians
Canada is not the only country to appreciate the benefits of clinical trials. Other countries organizing and competing for clinical trials – without compromising safety or quality – will win contracts from us. Global head offices sponsoring clinical trials will only invest in those countries that provide the best comparative return on investment for their increasingly scarce research dollars.
Our Strategic Partnerships
HealthCareCAN works in collaboration with partners to promote high-quality clinical research by sharing best practices, educational tools and resources, and promoting Canada as a world-leading destination for clinical trials, so that Canadians can continue to benefit from these innovative treatments.
The Canadian Clinical Trials Coordinating Centre
The Canadian Clinical Trials Coordinating Centre (CCTCC) was created to implement an action plan – “To Your Health and Prosperity – An Action Plan to Help Attract More Clinical Trials to Canada.” – to strengthen and improve clinical trials in Canada and streamline processes for companies and researchers. The action plan includes nine key recommendations to improve the coordination of clinical trials in Canada, increase participation in trials, and strategically raise Canada’s profile among international companies.
The Network of Networks
The Network of Networks (N2) is a not-for-profit incorporated organization and an alliance of Canadian research networks and organizations working to enhance national clinical research capability and capacity.
Under the Memorandum of Understanding, HealthcareCAN and N2facilitate joint goals in clinical research, particularly in the areas of education, advocacy, strategic coordination and alignment. N2 makes available a suite of compliant Standard Operating Procedures, education and training , and quality tools.